Example of a LaboratoryTestResult Bundle for antibiograms
{ "resourceType": "Bundle", "id": "HdBe-LaboratoryTestResult-Bundle-04-antibiogram", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult-Bundle" ] }, "identifier": { "system": "urn:ietf:rfc:3986", "value": "urn:uuid:0c3151bd-1ebf-4d91-b04d-cd9188a4c6e0" }, "type": "collection", "entry": [ { "fullUrl": "https://acme.org/Specimen/specimen50", "resource": { "resourceType": "Specimen", "id": "specimen50", "meta": { "versionId": "1", "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Specimen" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "identifier": [ { "system": "https://www.GTL-LABO.be/", "value": "1" } ], "status": "available", "type": { "coding": [ { "system": "http://snomed.info/sct", "code": "258529004", "display": "Throat swab" } ], "text": "A string can be added to nuance or explain." }, "receivedTime": "2015-11-04", "note": [ { "text": "Some extra relevant information concerning the specimen" } ] } }, { "fullUrl": "https://acme.org/Observation/org51", "resource": { "resourceType": "Observation", "id": "org51", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "73960-7", "display": "Bacteria identified in Mouth by Culture" } ] }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "valueCodeableConcept": { "coding": [ { "system": "http://snomed.info/sct", "code": "243301005", "display": "Morganella morganii" } ] }, "specimen": { "reference": "Specimen/specimen50" }, "hasMember": [ { "reference": "Observation/org51-ampicilin" }, { "reference": "Observation/org51-trimethoprim-sulfamethoxazole" }, { "reference": "Observation/org51-nitrofurantoin" }, { "reference": "Observation/org51-cefuroxime" }, { "reference": "Observation/org51-gentamicin" }, { "reference": "Observation/org51-colistin" }, { "reference": "Observation/org51-temocillin" }, { "reference": "Observation/org51-fosfomycin" }, { "reference": "Observation/org51-levofloxacin" }, { "reference": "Observation/org51-ofloxacin" }, { "reference": "Observation/org51-amoxicillin-clavulanate" }, { "reference": "Observation/org51-amikacin" }, { "reference": "Observation/org51-piperacillin-tazobactam" }, { "reference": "Observation/org51-ceftriaxone" }, { "reference": "Observation/org51-cefotaxime" }, { "reference": "Observation/org51-ceftazidime" }, { "reference": "Observation/org51-meropenem" } ] } }, { "fullUrl": "https://acme.org/Observation/org51-ampicilin", "resource": { "resourceType": "Observation", "id": "org51-ampicilin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "29-9", "display": "Ampicillin [Susceptibility] by Disk diffusion (KB)" } ], "text": "Ampicillin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "R", "display": "Resistant" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-trimethoprim-sulfamethoxazole", "resource": { "resourceType": "Observation", "id": "org51-trimethoprim-sulfamethoxazole", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "516-5", "display": "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Trimethoprim+Sulfamethoxazole" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-nitrofurantoin", "resource": { "resourceType": "Observation", "id": "org51-nitrofurantoin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "363-2", "display": "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Nitrofurantoin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "R", "display": "Resistant" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-cefuroxime", "resource": { "resourceType": "Observation", "id": "org51-cefuroxime", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "51774-8", "display": "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Cefuroxime" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "R", "display": "Resistant" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-gentamicin", "resource": { "resourceType": "Observation", "id": "org51-gentamicin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "267-5", "display": "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Gentamicin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-colistin", "resource": { "resourceType": "Observation", "id": "org51-colistin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "205-5", "display": "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Colistin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "R", "display": "Resistant" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-temocillin", "resource": { "resourceType": "Observation", "id": "org51-temocillin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "492-9", "display": "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Temocillin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-fosfomycin", "resource": { "resourceType": "Observation", "id": "org51-fosfomycin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "25653-7", "display": "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Fosfomycin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-levofloxacin", "resource": { "resourceType": "Observation", "id": "org51-levofloxacin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "20396-8", "display": "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Levofloxacin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-ofloxacin", "resource": { "resourceType": "Observation", "id": "org51-ofloxacin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "375-6", "display": "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Ofloxacin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-amoxicillin-clavulanate", "resource": { "resourceType": "Observation", "id": "org51-amoxicillin-clavulanate", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "20-8", "display": "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Amoxicillin+Clavulanate" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "R", "display": "Resistant" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-amikacin", "resource": { "resourceType": "Observation", "id": "org51-amikacin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "12-5", "display": "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Amikacin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-piperacillin-tazobactam", "resource": { "resourceType": "Observation", "id": "org51-piperacillin-tazobactam", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "412-7", "display": "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Piperacillin+Tazobactam" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-ceftriaxone", "resource": { "resourceType": "Observation", "id": "org51-ceftriaxone", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "141-2", "display": "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Ceftriaxone" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-cefotaxime", "resource": { "resourceType": "Observation", "id": "org51-cefotaxime", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "108-1", "display": "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Cefotaxime" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-ceftazidime", "resource": { "resourceType": "Observation", "id": "org51-ceftazidime", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "133-9", "display": "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Ceftazidime" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org51-meropenem", "resource": { "resourceType": "Observation", "id": "org51-meropenem", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "6652-2", "display": "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Meropenem" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52", "resource": { "resourceType": "Observation", "id": "org52", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "73960-7", "display": "Bacteria identified in Mouth by Culture" } ] }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "valueCodeableConcept": { "coding": [ { "system": "http://snomed.info/sct", "code": "112283007", "display": "Escherichia coli" } ] }, "specimen": { "reference": "Specimen/specimen50" }, "hasMember": [ { "reference": "Observation/org52-ampicilin" }, { "reference": "Observation/org52-trimethoprim-sulfamethoxazole" }, { "reference": "Observation/org52-nitrofurantoin" }, { "reference": "Observation/org52-cefuroxime" }, { "reference": "Observation/org52-gentamicin" }, { "reference": "Observation/org52-colistin" }, { "reference": "Observation/org52-temocillin" }, { "reference": "Observation/org52-fosfomycin" }, { "reference": "Observation/org52-levofloxacin" }, { "reference": "Observation/org52-ofloxacin" }, { "reference": "Observation/org52-amoxicillin-clavulanate" }, { "reference": "Observation/org52-amikacin" }, { "reference": "Observation/org52-piperacillin-tazobactam" }, { "reference": "Observation/org52-ceftriaxone" }, { "reference": "Observation/org52-cefotaxime" }, { "reference": "Observation/org52-ceftazidime" }, { "reference": "Observation/org52-meropenem" } ] } }, { "fullUrl": "https://acme.org/Observation/org52-ampicilin", "resource": { "resourceType": "Observation", "id": "org52-ampicilin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "29-9", "display": "Ampicillin [Susceptibility] by Disk diffusion (KB)" } ] }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-trimethoprim-sulfamethoxazole", "resource": { "resourceType": "Observation", "id": "org52-trimethoprim-sulfamethoxazole", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "516-5", "display": "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Trimethoprim+Sulfamethoxazole" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-nitrofurantoin", "resource": { "resourceType": "Observation", "id": "org52-nitrofurantoin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "363-2", "display": "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Nitrofurantoin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-cefuroxime", "resource": { "resourceType": "Observation", "id": "org52-cefuroxime", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "51774-8", "display": "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Cefuroxime" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-gentamicin", "resource": { "resourceType": "Observation", "id": "org52-gentamicin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "267-5", "display": "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Gentamicin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-colistin", "resource": { "resourceType": "Observation", "id": "org52-colistin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "205-5", "display": "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Colistin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-temocillin", "resource": { "resourceType": "Observation", "id": "org52-temocillin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "492-9", "display": "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Temocillin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-fosfomycin", "resource": { "resourceType": "Observation", "id": "org52-fosfomycin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "25653-7", "display": "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Fosfomycin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-levofloxacin", "resource": { "resourceType": "Observation", "id": "org52-levofloxacin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "20396-8", "display": "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Levofloxacin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-ofloxacin", "resource": { "resourceType": "Observation", "id": "org52-ofloxacin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "375-6", "display": "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Ofloxacin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-amoxicillin-clavulanate", "resource": { "resourceType": "Observation", "id": "org52-amoxicillin-clavulanate", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "20-8", "display": "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Amoxicillin+Clavulanate" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-amikacin", "resource": { "resourceType": "Observation", "id": "org52-amikacin", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "12-5", "display": "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Amikacin" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-piperacillin-tazobactam", "resource": { "resourceType": "Observation", "id": "org52-piperacillin-tazobactam", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "412-7", "display": "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Piperacillin+Tazobactam" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-ceftriaxone", "resource": { "resourceType": "Observation", "id": "org52-ceftriaxone", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "141-2", "display": "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Ceftriaxone" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-cefotaxime", "resource": { "resourceType": "Observation", "id": "org52-cefotaxime", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "108-1", "display": "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Cefotaxime" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-ceftazidime", "resource": { "resourceType": "Observation", "id": "org52-ceftazidime", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "133-9", "display": "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Ceftazidime" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/org52-meropenem", "resource": { "resourceType": "Observation", "id": "org52-meropenem", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "6652-2", "display": "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)" } ], "text": "Meropenem" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "interpretation": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "code": "S", "display": "Susceptible" } ] } ] } }, { "fullUrl": "https://acme.org/Observation/dr50-mrsa", "resource": { "resourceType": "Observation", "id": "dr50-mrsa", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "35492-8", "display": "Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection" } ], "text": "MRSA" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "valueString": "negative" } }, { "fullUrl": "https://acme.org/Observation/dr50-mrgn", "resource": { "resourceType": "Observation", "id": "dr50-mrgn", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "status": "final", "code": { "coding": [ { "system": "http://loinc.org", "code": "78702-8", "display": "Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture" } ], "text": "MRGN" }, "subject": { "reference": "Patient/patient1" }, "effectiveDateTime": "2015-11-04T09:16:00-05:00", "issued": "2015-11-04T09:16:00-05:00", "performer": [ { "reference": "Organization/organization10" } ], "valueString": "negative" } }, { "fullUrl": "https://acme.org/Organization/organization10", "resource": { "resourceType": "Organization", "id": "organization10", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-HealthcareOrganization-Organization" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "identifier": [ { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "MD", "display": "Medical License number" } ] }, "system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi", "value": "81165343998" } ], "active": true, "type": [ { "coding": [ { "system": "https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty", "code": "orglaboratory" } ] } ], "name": "GTL - General Testing Laboratory", "telecom": [ { "system": "phone", "value": "322675199", "use": "work" } ], "address": [ { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/language", "valueCode": "nl" } ], "use": "work", "type": "both", "text": "Vulcansstraat 120, 1000 Brussel", "line": [ "Vulcansstraat 120" ], "_line": [ { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName", "valueString": "Vulcansstraat" }, { "url": "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber", "valueString": "120" } ] } ], "city": "Brussel", "postalCode": "1000", "country": "BE" } ] } }, { "fullUrl": "https://acme.org/Patient/patient1", "resource": { "resourceType": "Patient", "id": "patient1", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-Patient" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "identifier": [ { "use": "official", "system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin", "value": "79121137740" } ], "active": true, "name": [ { "family": "La Paradisio", "given": [ "Josephine", "Nessa" ] } ], "telecom": [ { "system": "email", "value": "nessa.laparadisio@belgium.be" }, { "system": "phone", "value": "+322476792979", "use": "mobile" }, { "system": "phone", "value": "+3226718655", "use": "home" }, { "system": "phone", "value": "+322476799", "use": "work" } ], "gender": "female", "birthDate": "1979-12-11", "_birthDate": { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/patient-birthTime", "valueDateTime": "1979-12-11T13:28:17-05:00" } ] }, "address": [ { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/language", "valueCode": "nl" } ], "use": "home", "type": "both", "text": "Sloordelle 42, 1160 Oudergem", "line": [ "Sloordelle 42" ], "city": "Oudergem", "postalCode": "1160", "country": "BE" } ] } }, { "fullUrl": "https://acme.org/ServiceRequest/servicerequest50", "resource": { "resourceType": "ServiceRequest", "id": "servicerequest50", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Requester" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "identifier": [ { "system": "https://www.GTL-LABO.be/orderingsystem", "value": "12334546" } ], "status": "active", "intent": "order", "category": [ { "coding": [ { "system": "http://snomed.info/sct", "code": "108252007", "display": "Laboratory procedure" } ] } ], "subject": { "reference": "Patient/patient1" }, "authoredOn": "2015-11-01T14:41:00+01:00", "requester": { "reference": "Practitioner/practitioner1" }, "specimen": [ { "reference": "Specimen/specimen50" } ] } }, { "fullUrl": "https://acme.org/Practitioner/practitioner1", "resource": { "resourceType": "Practitioner", "id": "practitioner1", "meta": { "profile": [ "https://fhir.healthdata.be/StructureDefinition/HdBe-HealthProfessional-Practitioner" ] }, "text": { "status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">empty</div>" }, "identifier": [ { "use": "official", "system": "https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi", "value": "18749704477" } ], "name": [ { "use": "official", "family": "Pulaski", "given": [ "Katherine" ], "_given": [ { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/iso21090-EN-qualifier", "valueCode": "BR" } ] } ], "suffix": [ "MD" ] } ], "telecom": [ { "system": "email", "value": "katherine.pulaski@enterprisehospital.be", "use": "work" }, { "system": "phone", "value": "022675198", "use": "work" }, { "system": "fax", "value": "022675209", "use": "work" } ], "address": [ { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/language", "valueCode": "nl" } ], "use": "home", "text": "Jupiterlaan 5, 1853 Grimbergen", "line": [ "Jupiterlaan 5" ], "city": "Grimbergen", "postalCode": "1853", "country": "BE" } ] } } ] }
<Bundle xmlns="http://hl7.org/fhir"> <id value="HdBe-LaboratoryTestResult-Bundle-04-antibiogram" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult-Bundle" /> </meta> <identifier> <system value="urn:ietf:rfc:3986" /> <value value="urn:uuid:0c3151bd-1ebf-4d91-b04d-cd9188a4c6e0" /> </identifier> <type value="collection" /> <entry> <fullUrl value="https://acme.org/Specimen/specimen50" /> <resource> <Specimen> <id value="specimen50" /> <meta> <versionId value="1" /> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Specimen" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <identifier> <system value="https://www.GTL-LABO.be/" /> <value value="1" /> </identifier> <status value="available" /> <type> <coding> <system value="http://snomed.info/sct" /> <code value="258529004" /> <display value="Throat swab" /> </coding> <text value="A string can be added to nuance or explain." /> </type> <receivedTime value="2015-11-04" /> <note> <text value="Some extra relevant information concerning the specimen" /> </note> </Specimen> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51" /> <resource> <Observation> <id value="org51" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="73960-7" /> <display value="Bacteria identified in Mouth by Culture" /> </coding> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct" /> <code value="243301005" /> <display value="Morganella morganii" /> </coding> </valueCodeableConcept> <specimen> <reference value="Specimen/specimen50" /> </specimen> <hasMember> <reference value="Observation/org51-ampicilin" /> </hasMember> <hasMember> <reference value="Observation/org51-trimethoprim-sulfamethoxazole" /> </hasMember> <hasMember> <reference value="Observation/org51-nitrofurantoin" /> </hasMember> <hasMember> <reference value="Observation/org51-cefuroxime" /> </hasMember> <hasMember> <reference value="Observation/org51-gentamicin" /> </hasMember> <hasMember> <reference value="Observation/org51-colistin" /> </hasMember> <hasMember> <reference value="Observation/org51-temocillin" /> </hasMember> <hasMember> <reference value="Observation/org51-fosfomycin" /> </hasMember> <hasMember> <reference value="Observation/org51-levofloxacin" /> </hasMember> <hasMember> <reference value="Observation/org51-ofloxacin" /> </hasMember> <hasMember> <reference value="Observation/org51-amoxicillin-clavulanate" /> </hasMember> <hasMember> <reference value="Observation/org51-amikacin" /> </hasMember> <hasMember> <reference value="Observation/org51-piperacillin-tazobactam" /> </hasMember> <hasMember> <reference value="Observation/org51-ceftriaxone" /> </hasMember> <hasMember> <reference value="Observation/org51-cefotaxime" /> </hasMember> <hasMember> <reference value="Observation/org51-ceftazidime" /> </hasMember> <hasMember> <reference value="Observation/org51-meropenem" /> </hasMember> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-ampicilin" /> <resource> <Observation> <id value="org51-ampicilin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="29-9" /> <display value="Ampicillin [Susceptibility] by Disk diffusion (KB)" /> </coding> <text value="Ampicillin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="R" /> <display value="Resistant" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-trimethoprim-sulfamethoxazole" /> <resource> <Observation> <id value="org51-trimethoprim-sulfamethoxazole" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="516-5" /> <display value="Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Trimethoprim+Sulfamethoxazole" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-nitrofurantoin" /> <resource> <Observation> <id value="org51-nitrofurantoin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="363-2" /> <display value="Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Nitrofurantoin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="R" /> <display value="Resistant" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-cefuroxime" /> <resource> <Observation> <id value="org51-cefuroxime" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="51774-8" /> <display value="Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Cefuroxime" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="R" /> <display value="Resistant" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-gentamicin" /> <resource> <Observation> <id value="org51-gentamicin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="267-5" /> <display value="Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Gentamicin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-colistin" /> <resource> <Observation> <id value="org51-colistin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="205-5" /> <display value="Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Colistin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="R" /> <display value="Resistant" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-temocillin" /> <resource> <Observation> <id value="org51-temocillin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="492-9" /> <display value="Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Temocillin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-fosfomycin" /> <resource> <Observation> <id value="org51-fosfomycin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="25653-7" /> <display value="Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Fosfomycin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-levofloxacin" /> <resource> <Observation> <id value="org51-levofloxacin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="20396-8" /> <display value="levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Levofloxacin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-ofloxacin" /> <resource> <Observation> <id value="org51-ofloxacin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="375-6" /> <display value="Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Ofloxacin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-amoxicillin-clavulanate" /> <resource> <Observation> <id value="org51-amoxicillin-clavulanate" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="20-8" /> <display value="Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Amoxicillin+Clavulanate" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="R" /> <display value="Resistant" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-amikacin" /> <resource> <Observation> <id value="org51-amikacin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="12-5" /> <display value="Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Amikacin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-piperacillin-tazobactam" /> <resource> <Observation> <id value="org51-piperacillin-tazobactam" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="412-7" /> <display value="Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Piperacillin+Tazobactam" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-ceftriaxone" /> <resource> <Observation> <id value="org51-ceftriaxone" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="141-2" /> <display value="cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Ceftriaxone" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-cefotaxime" /> <resource> <Observation> <id value="org51-cefotaxime" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="108-1" /> <display value="Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Cefotaxime" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-ceftazidime" /> <resource> <Observation> <id value="org51-ceftazidime" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="133-9" /> <display value="cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Ceftazidime" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org51-meropenem" /> <resource> <Observation> <id value="org51-meropenem" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="6652-2" /> <display value="Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Meropenem" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52" /> <resource> <Observation> <id value="org52" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="73960-7" /> <display value="Bacteria identified in Mouth by Culture" /> </coding> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct" /> <code value="112283007" /> <display value="Escherichia coli" /> </coding> </valueCodeableConcept> <specimen> <reference value="Specimen/specimen50" /> </specimen> <hasMember> <reference value="Observation/org52-ampicilin" /> </hasMember> <hasMember> <reference value="Observation/org52-trimethoprim-sulfamethoxazole" /> </hasMember> <hasMember> <reference value="Observation/org52-nitrofurantoin" /> </hasMember> <hasMember> <reference value="Observation/org52-cefuroxime" /> </hasMember> <hasMember> <reference value="Observation/org52-gentamicin" /> </hasMember> <hasMember> <reference value="Observation/org52-colistin" /> </hasMember> <hasMember> <reference value="Observation/org52-temocillin" /> </hasMember> <hasMember> <reference value="Observation/org52-fosfomycin" /> </hasMember> <hasMember> <reference value="Observation/org52-levofloxacin" /> </hasMember> <hasMember> <reference value="Observation/org52-ofloxacin" /> </hasMember> <hasMember> <reference value="Observation/org52-amoxicillin-clavulanate" /> </hasMember> <hasMember> <reference value="Observation/org52-amikacin" /> </hasMember> <hasMember> <reference value="Observation/org52-piperacillin-tazobactam" /> </hasMember> <hasMember> <reference value="Observation/org52-ceftriaxone" /> </hasMember> <hasMember> <reference value="Observation/org52-cefotaxime" /> </hasMember> <hasMember> <reference value="Observation/org52-ceftazidime" /> </hasMember> <hasMember> <reference value="Observation/org52-meropenem" /> </hasMember> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-ampicilin" /> <resource> <Observation> <id value="org52-ampicilin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="29-9" /> <display value="Ampicillin [Susceptibility] by Disk diffusion (KB)" /> </coding> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-trimethoprim-sulfamethoxazole" /> <resource> <Observation> <id value="org52-trimethoprim-sulfamethoxazole" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="516-5" /> <display value="Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Trimethoprim+Sulfamethoxazole" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-nitrofurantoin" /> <resource> <Observation> <id value="org52-nitrofurantoin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="363-2" /> <display value="Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Nitrofurantoin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-cefuroxime" /> <resource> <Observation> <id value="org52-cefuroxime" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="51774-8" /> <display value="Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Cefuroxime" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-gentamicin" /> <resource> <Observation> <id value="org52-gentamicin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="267-5" /> <display value="Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Gentamicin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-colistin" /> <resource> <Observation> <id value="org52-colistin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="205-5" /> <display value="Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Colistin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-temocillin" /> <resource> <Observation> <id value="org52-temocillin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="492-9" /> <display value="Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Temocillin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-fosfomycin" /> <resource> <Observation> <id value="org52-fosfomycin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="25653-7" /> <display value="Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Fosfomycin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-levofloxacin" /> <resource> <Observation> <id value="org52-levofloxacin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="20396-8" /> <display value="levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Levofloxacin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-ofloxacin" /> <resource> <Observation> <id value="org52-ofloxacin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="375-6" /> <display value="Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Ofloxacin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-amoxicillin-clavulanate" /> <resource> <Observation> <id value="org52-amoxicillin-clavulanate" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="20-8" /> <display value="Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Amoxicillin+Clavulanate" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-amikacin" /> <resource> <Observation> <id value="org52-amikacin" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="12-5" /> <display value="Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Amikacin" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-piperacillin-tazobactam" /> <resource> <Observation> <id value="org52-piperacillin-tazobactam" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="412-7" /> <display value="Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Piperacillin+Tazobactam" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-ceftriaxone" /> <resource> <Observation> <id value="org52-ceftriaxone" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="141-2" /> <display value="cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Ceftriaxone" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-cefotaxime" /> <resource> <Observation> <id value="org52-cefotaxime" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="108-1" /> <display value="Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Cefotaxime" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-ceftazidime" /> <resource> <Observation> <id value="org52-ceftazidime" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="133-9" /> <display value="cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Ceftazidime" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/org52-meropenem" /> <resource> <Observation> <id value="org52-meropenem" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="6652-2" /> <display value="Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)" /> </coding> <text value="Meropenem" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <interpretation> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation" /> <code value="S" /> <display value="Susceptible" /> </coding> </interpretation> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/dr50-mrsa" /> <resource> <Observation> <id value="dr50-mrsa" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="35492-8" /> <display value="Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection" /> </coding> <text value="MRSA" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <valueString value="negative" /> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Observation/dr50-mrgn" /> <resource> <Observation> <id value="dr50-mrgn" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <status value="final" /> <code> <coding> <system value="http://loinc.org" /> <code value="78702-8" /> <display value="Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture" /> </coding> <text value="MRGN" /> </code> <subject> <reference value="Patient/patient1" /> </subject> <effectiveDateTime value="2015-11-04T09:16:00-05:00" /> <issued value="2015-11-04T09:16:00-05:00" /> <performer> <reference value="Organization/organization10" /> </performer> <valueString value="negative" /> </Observation> </resource> </entry> <entry> <fullUrl value="https://acme.org/Organization/organization10" /> <resource> <Organization> <id value="organization10" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-HealthcareOrganization-Organization" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <identifier> <use value="official" /> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/v2-0203" /> <code value="MD" /> <display value="Medical License number" /> </coding> </type> <system value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi" /> <value value="81165343998" /> </identifier> <active value="true" /> <type> <coding> <system value="https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty" /> <code value="orglaboratory" /> </coding> </type> <name value="GTL - General Testing Laboratory" /> <telecom> <system value="phone" /> <value value="322675199" /> <use value="work" /> </telecom> <address> <extension url="http://hl7.org/fhir/StructureDefinition/language"> <valueCode value="nl" /> </extension> <use value="work" /> <type value="both" /> <text value="Vulcansstraat 120, 1000 Brussel" /> <line value="Vulcansstraat 120"> <extension url="http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName"> <valueString value="Vulcansstraat" /> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber"> <valueString value="120" /> </extension> </line> <city value="Brussel" /> <postalCode value="1000" /> <country value="BE" /> </address> </Organization> </resource> </entry> <entry> <fullUrl value="https://acme.org/Patient/patient1" /> <resource> <Patient> <id value="patient1" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-Patient" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <identifier> <use value="official" /> <system value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin" /> <value value="79121137740" /> </identifier> <active value="true" /> <name> <family value="La Paradisio" /> <given value="Josephine" /> <given value="Nessa" /> </name> <telecom> <system value="email" /> <value value="nessa.laparadisio@belgium.be" /> </telecom> <telecom> <system value="phone" /> <value value="+322476792979" /> <use value="mobile" /> </telecom> <telecom> <system value="phone" /> <value value="+3226718655" /> <use value="home" /> </telecom> <telecom> <system value="phone" /> <value value="+322476799" /> <use value="work" /> </telecom> <gender value="female" /> <birthDate value="1979-12-11"> <extension url="http://hl7.org/fhir/StructureDefinition/patient-birthTime"> <valueDateTime value="1979-12-11T13:28:17-05:00" /> </extension> </birthDate> <address> <extension url="http://hl7.org/fhir/StructureDefinition/language"> <valueCode value="nl" /> </extension> <use value="home" /> <type value="both" /> <text value="Sloordelle 42, 1160 Oudergem" /> <line value="Sloordelle 42" /> <city value="Oudergem" /> <postalCode value="1160" /> <country value="BE" /> </address> </Patient> </resource> </entry> <entry> <fullUrl value="https://acme.org/ServiceRequest/servicerequest50" /> <resource> <ServiceRequest> <id value="servicerequest50" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Requester" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <identifier> <system value="https://www.GTL-LABO.be/orderingsystem" /> <value value="12334546" /> </identifier> <status value="active" /> <intent value="order" /> <category> <coding> <system value="http://snomed.info/sct" /> <code value="108252007" /> <display value="Laboratory procedure" /> </coding> </category> <subject> <reference value="Patient/patient1" /> </subject> <authoredOn value="2015-11-01T14:41:00+01:00" /> <requester> <reference value="Practitioner/practitioner1" /> </requester> <specimen> <reference value="Specimen/specimen50" /> </specimen> </ServiceRequest> </resource> </entry> <entry> <fullUrl value="https://acme.org/Practitioner/practitioner1" /> <resource> <Practitioner> <id value="practitioner1" /> <meta> <profile value="https://fhir.healthdata.be/StructureDefinition/HdBe-HealthProfessional-Practitioner" /> </meta> <text> <status value="empty" /> <div xmlns="http://www.w3.org/1999/xhtml">empty</div> </text> <identifier> <use value="official" /> <system value="https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi" /> <value value="18749704477" /> </identifier> <name> <use value="official" /> <family value="Pulaski" /> <given value="Katherine"> <extension url="http://hl7.org/fhir/StructureDefinition/iso21090-EN-qualifier"> <valueCode value="BR" /> </extension> </given> <suffix value="MD" /> </name> <telecom> <system value="email" /> <value value="katherine.pulaski@enterprisehospital.be" /> <use value="work" /> </telecom> <telecom> <system value="phone" /> <value value="022675198" /> <use value="work" /> </telecom> <telecom> <system value="fax" /> <value value="022675209" /> <use value="work" /> </telecom> <address> <extension url="http://hl7.org/fhir/StructureDefinition/language"> <valueCode value="nl" /> </extension> <use value="home" /> <text value="Jupiterlaan 5, 1853 Grimbergen" /> <line value="Jupiterlaan 5" /> <city value="Grimbergen" /> <postalCode value="1853" /> <country value="BE" /> </address> </Practitioner> </resource> </entry> </Bundle>
| Bundle |
| id : HdBe-LaboratoryTestResult-Bundle-04-antibiogram |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult-Bundle |
| identifier |
| system : urn:ietf:rfc:3986 |
| value : urn:uuid:0c3151bd-1ebf-4d91-b04d-cd9188a4c6e0 |
| type : collection |
| entry |
| fullUrl : https://acme.org/Specimen/specimen50 |
| resource |
| id : specimen50 |
| meta |
| versionId : 1 |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Specimen |
| text |
| status : empty |
| identifier |
| system : https://www.GTL-LABO.be/ |
| value : 1 |
| status : available |
| type |
| coding |
| system : http://snomed.info/sct |
| code : 258529004 |
| display : Throat swab |
| text : A string can be added to nuance or explain. |
| receivedTime : 2015-11-04 |
| note |
| text : Some extra relevant information concerning the specimen |
| entry |
| fullUrl : https://acme.org/Observation/org51 |
| resource |
| id : org51 |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 73960-7 |
| display : Bacteria identified in Mouth by Culture |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| value |
| coding |
| system : http://snomed.info/sct |
| code : 243301005 |
| display : Morganella morganii |
| specimen |
| reference : Specimen/specimen50 |
| hasMember |
| reference : Observation/org51-ampicilin |
| hasMember |
| reference : Observation/org51-trimethoprim-sulfamethoxazole |
| hasMember |
| reference : Observation/org51-nitrofurantoin |
| hasMember |
| reference : Observation/org51-cefuroxime |
| hasMember |
| reference : Observation/org51-gentamicin |
| hasMember |
| reference : Observation/org51-colistin |
| hasMember |
| reference : Observation/org51-temocillin |
| hasMember |
| reference : Observation/org51-fosfomycin |
| hasMember |
| reference : Observation/org51-levofloxacin |
| hasMember |
| reference : Observation/org51-ofloxacin |
| hasMember |
| reference : Observation/org51-amoxicillin-clavulanate |
| hasMember |
| reference : Observation/org51-amikacin |
| hasMember |
| reference : Observation/org51-piperacillin-tazobactam |
| hasMember |
| reference : Observation/org51-ceftriaxone |
| hasMember |
| reference : Observation/org51-cefotaxime |
| hasMember |
| reference : Observation/org51-ceftazidime |
| hasMember |
| reference : Observation/org51-meropenem |
| entry |
| fullUrl : https://acme.org/Observation/org51-ampicilin |
| resource |
| id : org51-ampicilin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 29-9 |
| display : Ampicillin [Susceptibility] by Disk diffusion (KB) |
| text : Ampicillin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : R |
| display : Resistant |
| entry |
| fullUrl : https://acme.org/Observation/org51-trimethoprim-sulfamethoxazole |
| resource |
| id : org51-trimethoprim-sulfamethoxazole |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 516-5 |
| display : Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Trimethoprim+Sulfamethoxazole |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-nitrofurantoin |
| resource |
| id : org51-nitrofurantoin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 363-2 |
| display : Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Nitrofurantoin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : R |
| display : Resistant |
| entry |
| fullUrl : https://acme.org/Observation/org51-cefuroxime |
| resource |
| id : org51-cefuroxime |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 51774-8 |
| display : Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Cefuroxime |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : R |
| display : Resistant |
| entry |
| fullUrl : https://acme.org/Observation/org51-gentamicin |
| resource |
| id : org51-gentamicin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 267-5 |
| display : Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Gentamicin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-colistin |
| resource |
| id : org51-colistin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 205-5 |
| display : Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Colistin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : R |
| display : Resistant |
| entry |
| fullUrl : https://acme.org/Observation/org51-temocillin |
| resource |
| id : org51-temocillin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 492-9 |
| display : Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Temocillin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-fosfomycin |
| resource |
| id : org51-fosfomycin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 25653-7 |
| display : Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Fosfomycin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-levofloxacin |
| resource |
| id : org51-levofloxacin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 20396-8 |
| display : levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Levofloxacin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-ofloxacin |
| resource |
| id : org51-ofloxacin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 375-6 |
| display : Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Ofloxacin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-amoxicillin-clavulanate |
| resource |
| id : org51-amoxicillin-clavulanate |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 20-8 |
| display : Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Amoxicillin+Clavulanate |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : R |
| display : Resistant |
| entry |
| fullUrl : https://acme.org/Observation/org51-amikacin |
| resource |
| id : org51-amikacin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 12-5 |
| display : Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Amikacin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-piperacillin-tazobactam |
| resource |
| id : org51-piperacillin-tazobactam |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 412-7 |
| display : Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Piperacillin+Tazobactam |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-ceftriaxone |
| resource |
| id : org51-ceftriaxone |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 141-2 |
| display : cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Ceftriaxone |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-cefotaxime |
| resource |
| id : org51-cefotaxime |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 108-1 |
| display : Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Cefotaxime |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-ceftazidime |
| resource |
| id : org51-ceftazidime |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 133-9 |
| display : cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Ceftazidime |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org51-meropenem |
| resource |
| id : org51-meropenem |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 6652-2 |
| display : Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Meropenem |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52 |
| resource |
| id : org52 |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 73960-7 |
| display : Bacteria identified in Mouth by Culture |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| value |
| coding |
| system : http://snomed.info/sct |
| code : 112283007 |
| display : Escherichia coli |
| specimen |
| reference : Specimen/specimen50 |
| hasMember |
| reference : Observation/org52-ampicilin |
| hasMember |
| reference : Observation/org52-trimethoprim-sulfamethoxazole |
| hasMember |
| reference : Observation/org52-nitrofurantoin |
| hasMember |
| reference : Observation/org52-cefuroxime |
| hasMember |
| reference : Observation/org52-gentamicin |
| hasMember |
| reference : Observation/org52-colistin |
| hasMember |
| reference : Observation/org52-temocillin |
| hasMember |
| reference : Observation/org52-fosfomycin |
| hasMember |
| reference : Observation/org52-levofloxacin |
| hasMember |
| reference : Observation/org52-ofloxacin |
| hasMember |
| reference : Observation/org52-amoxicillin-clavulanate |
| hasMember |
| reference : Observation/org52-amikacin |
| hasMember |
| reference : Observation/org52-piperacillin-tazobactam |
| hasMember |
| reference : Observation/org52-ceftriaxone |
| hasMember |
| reference : Observation/org52-cefotaxime |
| hasMember |
| reference : Observation/org52-ceftazidime |
| hasMember |
| reference : Observation/org52-meropenem |
| entry |
| fullUrl : https://acme.org/Observation/org52-ampicilin |
| resource |
| id : org52-ampicilin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 29-9 |
| display : Ampicillin [Susceptibility] by Disk diffusion (KB) |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-trimethoprim-sulfamethoxazole |
| resource |
| id : org52-trimethoprim-sulfamethoxazole |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 516-5 |
| display : Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Trimethoprim+Sulfamethoxazole |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-nitrofurantoin |
| resource |
| id : org52-nitrofurantoin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 363-2 |
| display : Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Nitrofurantoin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-cefuroxime |
| resource |
| id : org52-cefuroxime |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 51774-8 |
| display : Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Cefuroxime |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-gentamicin |
| resource |
| id : org52-gentamicin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 267-5 |
| display : Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Gentamicin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-colistin |
| resource |
| id : org52-colistin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 205-5 |
| display : Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Colistin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-temocillin |
| resource |
| id : org52-temocillin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 492-9 |
| display : Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Temocillin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-fosfomycin |
| resource |
| id : org52-fosfomycin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 25653-7 |
| display : Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Fosfomycin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-levofloxacin |
| resource |
| id : org52-levofloxacin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 20396-8 |
| display : levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Levofloxacin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-ofloxacin |
| resource |
| id : org52-ofloxacin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 375-6 |
| display : Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Ofloxacin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-amoxicillin-clavulanate |
| resource |
| id : org52-amoxicillin-clavulanate |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 20-8 |
| display : Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Amoxicillin+Clavulanate |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-amikacin |
| resource |
| id : org52-amikacin |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 12-5 |
| display : Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Amikacin |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-piperacillin-tazobactam |
| resource |
| id : org52-piperacillin-tazobactam |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 412-7 |
| display : Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Piperacillin+Tazobactam |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-ceftriaxone |
| resource |
| id : org52-ceftriaxone |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 141-2 |
| display : cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Ceftriaxone |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-cefotaxime |
| resource |
| id : org52-cefotaxime |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 108-1 |
| display : Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Cefotaxime |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-ceftazidime |
| resource |
| id : org52-ceftazidime |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 133-9 |
| display : cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Ceftazidime |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/org52-meropenem |
| resource |
| id : org52-meropenem |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 6652-2 |
| display : Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| text : Meropenem |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| interpretation |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| code : S |
| display : Susceptible |
| entry |
| fullUrl : https://acme.org/Observation/dr50-mrsa |
| resource |
| id : dr50-mrsa |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 35492-8 |
| display : Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection |
| text : MRSA |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| value : negative |
| entry |
| fullUrl : https://acme.org/Observation/dr50-mrgn |
| resource |
| id : dr50-mrgn |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| text |
| status : empty |
| status : final |
| code |
| coding |
| system : http://loinc.org |
| code : 78702-8 |
| display : Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture |
| text : MRGN |
| subject |
| reference : Patient/patient1 |
| effective : 2015-11-04T09:16:00-05:00 |
| issued : 2015-11-04T09:16:00-05:00 |
| performer |
| reference : Organization/organization10 |
| value : negative |
| entry |
| fullUrl : https://acme.org/Organization/organization10 |
| resource |
| id : organization10 |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-HealthcareOrganization-Organization |
| text |
| status : empty |
| identifier |
| use : official |
| type |
| coding |
| system : http://terminology.hl7.org/CodeSystem/v2-0203 |
| code : MD |
| display : Medical License number |
| system : https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi |
| value : 81165343998 |
| active : True |
| type |
| coding |
| system : https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty |
| code : orglaboratory |
| name : GTL - General Testing Laboratory |
| telecom |
| system : phone |
| value : 322675199 |
| use : work |
| address |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/language |
| value : nl |
| use : work |
| type : both |
| text : Vulcansstraat 120, 1000 Brussel |
| line : Vulcansstraat 120 |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName |
| value : Vulcansstraat |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber |
| value : 120 |
| city : Brussel |
| postalCode : 1000 |
| country : BE |
| entry |
| fullUrl : https://acme.org/Patient/patient1 |
| resource |
| id : patient1 |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-Patient |
| text |
| status : empty |
| identifier |
| use : official |
| system : https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin |
| value : 79121137740 |
| active : True |
| name |
| family : La Paradisio |
| given : Josephine |
| given : Nessa |
| telecom |
| system : email |
| value : nessa.laparadisio@belgium.be |
| telecom |
| system : phone |
| value : +322476792979 |
| use : mobile |
| telecom |
| system : phone |
| value : +3226718655 |
| use : home |
| telecom |
| system : phone |
| value : +322476799 |
| use : work |
| gender : female |
| birthDate : 1979-12-11 |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/patient-birthTime |
| value : 1979-12-11T13:28:17-05:00 |
| address |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/language |
| value : nl |
| use : home |
| type : both |
| text : Sloordelle 42, 1160 Oudergem |
| line : Sloordelle 42 |
| city : Oudergem |
| postalCode : 1160 |
| country : BE |
| entry |
| fullUrl : https://acme.org/ServiceRequest/servicerequest50 |
| resource |
| id : servicerequest50 |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Requester |
| text |
| status : empty |
| identifier |
| system : https://www.GTL-LABO.be/orderingsystem |
| value : 12334546 |
| status : active |
| intent : order |
| category |
| coding |
| system : http://snomed.info/sct |
| code : 108252007 |
| display : Laboratory procedure |
| subject |
| reference : Patient/patient1 |
| authoredOn : 2015-11-01T14:41:00+01:00 |
| requester |
| reference : Practitioner/practitioner1 |
| specimen |
| reference : Specimen/specimen50 |
| entry |
| fullUrl : https://acme.org/Practitioner/practitioner1 |
| resource |
| id : practitioner1 |
| meta |
| profile : https://fhir.healthdata.be/StructureDefinition/HdBe-HealthProfessional-Practitioner |
| text |
| status : empty |
| identifier |
| use : official |
| system : https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi |
| value : 18749704477 |
| name |
| use : official |
| family : Pulaski |
| given : Katherine |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/iso21090-EN-qualifier |
| value : BR |
| suffix : MD |
| telecom |
| system : email |
| value : katherine.pulaski@enterprisehospital.be |
| use : work |
| telecom |
| system : phone |
| value : 022675198 |
| use : work |
| telecom |
| system : fax |
| value : 022675209 |
| use : work |
| address |
| extension |
| url : http://hl7.org/fhir/StructureDefinition/language |
| value : nl |
| use : home |
| text : Jupiterlaan 5, 1853 Grimbergen |
| line : Jupiterlaan 5 |
| city : Grimbergen |
| postalCode : 1853 |
| country : BE |
| Bundle.id[0] | HdBe-LaboratoryTestResult-Bundle-04-antibiogram |
| Bundle.meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult-Bundle |
| Bundle.identifier[0].system[0] | urn:ietf:rfc:3986 |
| Bundle.identifier[0].value[0] | urn:uuid:0c3151bd-1ebf-4d91-b04d-cd9188a4c6e0 |
| Bundle.type[0] | collection |
| Bundle.entry[0].fullUrl[0] | https://acme.org/Specimen/specimen50 |
| Bundle.entry[0].resource[0].id[0] | specimen50 |
| Bundle.entry[0].resource[0].meta[0].versionId[0] | 1 |
| Bundle.entry[0].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Specimen |
| Bundle.entry[0].resource[0].text[0].status[0] | empty |
| Bundle.entry[0].resource[0].text[0].div[0] | empty |
| Bundle.entry[0].resource[0].identifier[0].system[0] | https://www.GTL-LABO.be/ |
| Bundle.entry[0].resource[0].identifier[0].value[0] | 1 |
| Bundle.entry[0].resource[0].status[0] | available |
| Bundle.entry[0].resource[0].type[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[0].resource[0].type[0].coding[0].code[0] | 258529004 |
| Bundle.entry[0].resource[0].type[0].coding[0].display[0] | Throat swab |
| Bundle.entry[0].resource[0].type[0].text[0] | A string can be added to nuance or explain. |
| Bundle.entry[0].resource[0].receivedTime[0] | 2015-11-04 |
| Bundle.entry[0].resource[0].note[0].text[0] | Some extra relevant information concerning the specimen |
| Bundle.entry[1].fullUrl[0] | https://acme.org/Observation/org51 |
| Bundle.entry[1].resource[0].id[0] | org51 |
| Bundle.entry[1].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[1].resource[0].text[0].status[0] | empty |
| Bundle.entry[1].resource[0].text[0].div[0] | empty |
| Bundle.entry[1].resource[0].status[0] | final |
| Bundle.entry[1].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[1].resource[0].code[0].coding[0].code[0] | 73960-7 |
| Bundle.entry[1].resource[0].code[0].coding[0].display[0] | Bacteria identified in Mouth by Culture |
| Bundle.entry[1].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[1].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[1].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[1].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[1].resource[0].valueCodeableConcept[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[1].resource[0].valueCodeableConcept[0].coding[0].code[0] | 243301005 |
| Bundle.entry[1].resource[0].valueCodeableConcept[0].coding[0].display[0] | Morganella morganii |
| Bundle.entry[1].resource[0].specimen[0].reference[0] | Specimen/specimen50 |
| Bundle.entry[1].resource[0].hasMember[0].reference[0] | Observation/org51-ampicilin |
| Bundle.entry[1].resource[0].hasMember[1].reference[0] | Observation/org51-trimethoprim-sulfamethoxazole |
| Bundle.entry[1].resource[0].hasMember[2].reference[0] | Observation/org51-nitrofurantoin |
| Bundle.entry[1].resource[0].hasMember[3].reference[0] | Observation/org51-cefuroxime |
| Bundle.entry[1].resource[0].hasMember[4].reference[0] | Observation/org51-gentamicin |
| Bundle.entry[1].resource[0].hasMember[5].reference[0] | Observation/org51-colistin |
| Bundle.entry[1].resource[0].hasMember[6].reference[0] | Observation/org51-temocillin |
| Bundle.entry[1].resource[0].hasMember[7].reference[0] | Observation/org51-fosfomycin |
| Bundle.entry[1].resource[0].hasMember[8].reference[0] | Observation/org51-levofloxacin |
| Bundle.entry[1].resource[0].hasMember[9].reference[0] | Observation/org51-ofloxacin |
| Bundle.entry[1].resource[0].hasMember[10].reference[0] | Observation/org51-amoxicillin-clavulanate |
| Bundle.entry[1].resource[0].hasMember[11].reference[0] | Observation/org51-amikacin |
| Bundle.entry[1].resource[0].hasMember[12].reference[0] | Observation/org51-piperacillin-tazobactam |
| Bundle.entry[1].resource[0].hasMember[13].reference[0] | Observation/org51-ceftriaxone |
| Bundle.entry[1].resource[0].hasMember[14].reference[0] | Observation/org51-cefotaxime |
| Bundle.entry[1].resource[0].hasMember[15].reference[0] | Observation/org51-ceftazidime |
| Bundle.entry[1].resource[0].hasMember[16].reference[0] | Observation/org51-meropenem |
| Bundle.entry[2].fullUrl[0] | https://acme.org/Observation/org51-ampicilin |
| Bundle.entry[2].resource[0].id[0] | org51-ampicilin |
| Bundle.entry[2].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[2].resource[0].text[0].status[0] | empty |
| Bundle.entry[2].resource[0].text[0].div[0] | empty |
| Bundle.entry[2].resource[0].status[0] | final |
| Bundle.entry[2].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[2].resource[0].code[0].coding[0].code[0] | 29-9 |
| Bundle.entry[2].resource[0].code[0].coding[0].display[0] | Ampicillin [Susceptibility] by Disk diffusion (KB) |
| Bundle.entry[2].resource[0].code[0].text[0] | Ampicillin |
| Bundle.entry[2].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[2].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[2].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[2].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[2].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[2].resource[0].interpretation[0].coding[0].code[0] | R |
| Bundle.entry[2].resource[0].interpretation[0].coding[0].display[0] | Resistant |
| Bundle.entry[3].fullUrl[0] | https://acme.org/Observation/org51-trimethoprim-sulfamethoxazole |
| Bundle.entry[3].resource[0].id[0] | org51-trimethoprim-sulfamethoxazole |
| Bundle.entry[3].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[3].resource[0].text[0].status[0] | empty |
| Bundle.entry[3].resource[0].text[0].div[0] | empty |
| Bundle.entry[3].resource[0].status[0] | final |
| Bundle.entry[3].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[3].resource[0].code[0].coding[0].code[0] | 516-5 |
| Bundle.entry[3].resource[0].code[0].coding[0].display[0] | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[3].resource[0].code[0].text[0] | Trimethoprim+Sulfamethoxazole |
| Bundle.entry[3].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[3].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[3].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[3].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[3].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[3].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[3].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[4].fullUrl[0] | https://acme.org/Observation/org51-nitrofurantoin |
| Bundle.entry[4].resource[0].id[0] | org51-nitrofurantoin |
| Bundle.entry[4].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[4].resource[0].text[0].status[0] | empty |
| Bundle.entry[4].resource[0].text[0].div[0] | empty |
| Bundle.entry[4].resource[0].status[0] | final |
| Bundle.entry[4].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[4].resource[0].code[0].coding[0].code[0] | 363-2 |
| Bundle.entry[4].resource[0].code[0].coding[0].display[0] | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[4].resource[0].code[0].text[0] | Nitrofurantoin |
| Bundle.entry[4].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[4].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[4].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[4].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[4].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[4].resource[0].interpretation[0].coding[0].code[0] | R |
| Bundle.entry[4].resource[0].interpretation[0].coding[0].display[0] | Resistant |
| Bundle.entry[5].fullUrl[0] | https://acme.org/Observation/org51-cefuroxime |
| Bundle.entry[5].resource[0].id[0] | org51-cefuroxime |
| Bundle.entry[5].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[5].resource[0].text[0].status[0] | empty |
| Bundle.entry[5].resource[0].text[0].div[0] | empty |
| Bundle.entry[5].resource[0].status[0] | final |
| Bundle.entry[5].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[5].resource[0].code[0].coding[0].code[0] | 51774-8 |
| Bundle.entry[5].resource[0].code[0].coding[0].display[0] | Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[5].resource[0].code[0].text[0] | Cefuroxime |
| Bundle.entry[5].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[5].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[5].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[5].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[5].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[5].resource[0].interpretation[0].coding[0].code[0] | R |
| Bundle.entry[5].resource[0].interpretation[0].coding[0].display[0] | Resistant |
| Bundle.entry[6].fullUrl[0] | https://acme.org/Observation/org51-gentamicin |
| Bundle.entry[6].resource[0].id[0] | org51-gentamicin |
| Bundle.entry[6].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[6].resource[0].text[0].status[0] | empty |
| Bundle.entry[6].resource[0].text[0].div[0] | empty |
| Bundle.entry[6].resource[0].status[0] | final |
| Bundle.entry[6].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[6].resource[0].code[0].coding[0].code[0] | 267-5 |
| Bundle.entry[6].resource[0].code[0].coding[0].display[0] | Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[6].resource[0].code[0].text[0] | Gentamicin |
| Bundle.entry[6].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[6].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[6].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[6].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[6].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[6].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[6].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[7].fullUrl[0] | https://acme.org/Observation/org51-colistin |
| Bundle.entry[7].resource[0].id[0] | org51-colistin |
| Bundle.entry[7].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[7].resource[0].text[0].status[0] | empty |
| Bundle.entry[7].resource[0].text[0].div[0] | empty |
| Bundle.entry[7].resource[0].status[0] | final |
| Bundle.entry[7].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[7].resource[0].code[0].coding[0].code[0] | 205-5 |
| Bundle.entry[7].resource[0].code[0].coding[0].display[0] | Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[7].resource[0].code[0].text[0] | Colistin |
| Bundle.entry[7].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[7].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[7].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[7].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[7].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[7].resource[0].interpretation[0].coding[0].code[0] | R |
| Bundle.entry[7].resource[0].interpretation[0].coding[0].display[0] | Resistant |
| Bundle.entry[8].fullUrl[0] | https://acme.org/Observation/org51-temocillin |
| Bundle.entry[8].resource[0].id[0] | org51-temocillin |
| Bundle.entry[8].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[8].resource[0].text[0].status[0] | empty |
| Bundle.entry[8].resource[0].text[0].div[0] | empty |
| Bundle.entry[8].resource[0].status[0] | final |
| Bundle.entry[8].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[8].resource[0].code[0].coding[0].code[0] | 492-9 |
| Bundle.entry[8].resource[0].code[0].coding[0].display[0] | Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[8].resource[0].code[0].text[0] | Temocillin |
| Bundle.entry[8].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[8].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[8].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[8].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[8].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[8].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[8].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[9].fullUrl[0] | https://acme.org/Observation/org51-fosfomycin |
| Bundle.entry[9].resource[0].id[0] | org51-fosfomycin |
| Bundle.entry[9].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[9].resource[0].text[0].status[0] | empty |
| Bundle.entry[9].resource[0].text[0].div[0] | empty |
| Bundle.entry[9].resource[0].status[0] | final |
| Bundle.entry[9].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[9].resource[0].code[0].coding[0].code[0] | 25653-7 |
| Bundle.entry[9].resource[0].code[0].coding[0].display[0] | Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[9].resource[0].code[0].text[0] | Fosfomycin |
| Bundle.entry[9].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[9].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[9].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[9].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[9].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[9].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[9].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[10].fullUrl[0] | https://acme.org/Observation/org51-levofloxacin |
| Bundle.entry[10].resource[0].id[0] | org51-levofloxacin |
| Bundle.entry[10].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[10].resource[0].text[0].status[0] | empty |
| Bundle.entry[10].resource[0].text[0].div[0] | empty |
| Bundle.entry[10].resource[0].status[0] | final |
| Bundle.entry[10].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[10].resource[0].code[0].coding[0].code[0] | 20396-8 |
| Bundle.entry[10].resource[0].code[0].coding[0].display[0] | levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[10].resource[0].code[0].text[0] | Levofloxacin |
| Bundle.entry[10].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[10].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[10].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[10].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[10].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[10].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[10].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[11].fullUrl[0] | https://acme.org/Observation/org51-ofloxacin |
| Bundle.entry[11].resource[0].id[0] | org51-ofloxacin |
| Bundle.entry[11].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[11].resource[0].text[0].status[0] | empty |
| Bundle.entry[11].resource[0].text[0].div[0] | empty |
| Bundle.entry[11].resource[0].status[0] | final |
| Bundle.entry[11].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[11].resource[0].code[0].coding[0].code[0] | 375-6 |
| Bundle.entry[11].resource[0].code[0].coding[0].display[0] | Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[11].resource[0].code[0].text[0] | Ofloxacin |
| Bundle.entry[11].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[11].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[11].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[11].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[11].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[11].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[11].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[12].fullUrl[0] | https://acme.org/Observation/org51-amoxicillin-clavulanate |
| Bundle.entry[12].resource[0].id[0] | org51-amoxicillin-clavulanate |
| Bundle.entry[12].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[12].resource[0].text[0].status[0] | empty |
| Bundle.entry[12].resource[0].text[0].div[0] | empty |
| Bundle.entry[12].resource[0].status[0] | final |
| Bundle.entry[12].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[12].resource[0].code[0].coding[0].code[0] | 20-8 |
| Bundle.entry[12].resource[0].code[0].coding[0].display[0] | Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[12].resource[0].code[0].text[0] | Amoxicillin+Clavulanate |
| Bundle.entry[12].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[12].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[12].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[12].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[12].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[12].resource[0].interpretation[0].coding[0].code[0] | R |
| Bundle.entry[12].resource[0].interpretation[0].coding[0].display[0] | Resistant |
| Bundle.entry[13].fullUrl[0] | https://acme.org/Observation/org51-amikacin |
| Bundle.entry[13].resource[0].id[0] | org51-amikacin |
| Bundle.entry[13].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[13].resource[0].text[0].status[0] | empty |
| Bundle.entry[13].resource[0].text[0].div[0] | empty |
| Bundle.entry[13].resource[0].status[0] | final |
| Bundle.entry[13].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[13].resource[0].code[0].coding[0].code[0] | 12-5 |
| Bundle.entry[13].resource[0].code[0].coding[0].display[0] | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[13].resource[0].code[0].text[0] | Amikacin |
| Bundle.entry[13].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[13].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[13].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[13].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[13].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[13].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[13].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[14].fullUrl[0] | https://acme.org/Observation/org51-piperacillin-tazobactam |
| Bundle.entry[14].resource[0].id[0] | org51-piperacillin-tazobactam |
| Bundle.entry[14].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[14].resource[0].text[0].status[0] | empty |
| Bundle.entry[14].resource[0].text[0].div[0] | empty |
| Bundle.entry[14].resource[0].status[0] | final |
| Bundle.entry[14].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[14].resource[0].code[0].coding[0].code[0] | 412-7 |
| Bundle.entry[14].resource[0].code[0].coding[0].display[0] | Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[14].resource[0].code[0].text[0] | Piperacillin+Tazobactam |
| Bundle.entry[14].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[14].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[14].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[14].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[14].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[14].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[14].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[15].fullUrl[0] | https://acme.org/Observation/org51-ceftriaxone |
| Bundle.entry[15].resource[0].id[0] | org51-ceftriaxone |
| Bundle.entry[15].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[15].resource[0].text[0].status[0] | empty |
| Bundle.entry[15].resource[0].text[0].div[0] | empty |
| Bundle.entry[15].resource[0].status[0] | final |
| Bundle.entry[15].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[15].resource[0].code[0].coding[0].code[0] | 141-2 |
| Bundle.entry[15].resource[0].code[0].coding[0].display[0] | cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[15].resource[0].code[0].text[0] | Ceftriaxone |
| Bundle.entry[15].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[15].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[15].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[15].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[15].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[15].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[15].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[16].fullUrl[0] | https://acme.org/Observation/org51-cefotaxime |
| Bundle.entry[16].resource[0].id[0] | org51-cefotaxime |
| Bundle.entry[16].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[16].resource[0].text[0].status[0] | empty |
| Bundle.entry[16].resource[0].text[0].div[0] | empty |
| Bundle.entry[16].resource[0].status[0] | final |
| Bundle.entry[16].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[16].resource[0].code[0].coding[0].code[0] | 108-1 |
| Bundle.entry[16].resource[0].code[0].coding[0].display[0] | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[16].resource[0].code[0].text[0] | Cefotaxime |
| Bundle.entry[16].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[16].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[16].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[16].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[16].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[16].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[16].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[17].fullUrl[0] | https://acme.org/Observation/org51-ceftazidime |
| Bundle.entry[17].resource[0].id[0] | org51-ceftazidime |
| Bundle.entry[17].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[17].resource[0].text[0].status[0] | empty |
| Bundle.entry[17].resource[0].text[0].div[0] | empty |
| Bundle.entry[17].resource[0].status[0] | final |
| Bundle.entry[17].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[17].resource[0].code[0].coding[0].code[0] | 133-9 |
| Bundle.entry[17].resource[0].code[0].coding[0].display[0] | cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[17].resource[0].code[0].text[0] | Ceftazidime |
| Bundle.entry[17].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[17].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[17].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[17].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[17].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[17].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[17].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[18].fullUrl[0] | https://acme.org/Observation/org51-meropenem |
| Bundle.entry[18].resource[0].id[0] | org51-meropenem |
| Bundle.entry[18].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[18].resource[0].text[0].status[0] | empty |
| Bundle.entry[18].resource[0].text[0].div[0] | empty |
| Bundle.entry[18].resource[0].status[0] | final |
| Bundle.entry[18].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[18].resource[0].code[0].coding[0].code[0] | 6652-2 |
| Bundle.entry[18].resource[0].code[0].coding[0].display[0] | Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[18].resource[0].code[0].text[0] | Meropenem |
| Bundle.entry[18].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[18].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[18].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[18].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[18].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[18].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[18].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[19].fullUrl[0] | https://acme.org/Observation/org52 |
| Bundle.entry[19].resource[0].id[0] | org52 |
| Bundle.entry[19].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[19].resource[0].text[0].status[0] | empty |
| Bundle.entry[19].resource[0].text[0].div[0] | empty |
| Bundle.entry[19].resource[0].status[0] | final |
| Bundle.entry[19].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[19].resource[0].code[0].coding[0].code[0] | 73960-7 |
| Bundle.entry[19].resource[0].code[0].coding[0].display[0] | Bacteria identified in Mouth by Culture |
| Bundle.entry[19].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[19].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[19].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[19].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[19].resource[0].valueCodeableConcept[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[19].resource[0].valueCodeableConcept[0].coding[0].code[0] | 112283007 |
| Bundle.entry[19].resource[0].valueCodeableConcept[0].coding[0].display[0] | Escherichia coli |
| Bundle.entry[19].resource[0].specimen[0].reference[0] | Specimen/specimen50 |
| Bundle.entry[19].resource[0].hasMember[0].reference[0] | Observation/org52-ampicilin |
| Bundle.entry[19].resource[0].hasMember[1].reference[0] | Observation/org52-trimethoprim-sulfamethoxazole |
| Bundle.entry[19].resource[0].hasMember[2].reference[0] | Observation/org52-nitrofurantoin |
| Bundle.entry[19].resource[0].hasMember[3].reference[0] | Observation/org52-cefuroxime |
| Bundle.entry[19].resource[0].hasMember[4].reference[0] | Observation/org52-gentamicin |
| Bundle.entry[19].resource[0].hasMember[5].reference[0] | Observation/org52-colistin |
| Bundle.entry[19].resource[0].hasMember[6].reference[0] | Observation/org52-temocillin |
| Bundle.entry[19].resource[0].hasMember[7].reference[0] | Observation/org52-fosfomycin |
| Bundle.entry[19].resource[0].hasMember[8].reference[0] | Observation/org52-levofloxacin |
| Bundle.entry[19].resource[0].hasMember[9].reference[0] | Observation/org52-ofloxacin |
| Bundle.entry[19].resource[0].hasMember[10].reference[0] | Observation/org52-amoxicillin-clavulanate |
| Bundle.entry[19].resource[0].hasMember[11].reference[0] | Observation/org52-amikacin |
| Bundle.entry[19].resource[0].hasMember[12].reference[0] | Observation/org52-piperacillin-tazobactam |
| Bundle.entry[19].resource[0].hasMember[13].reference[0] | Observation/org52-ceftriaxone |
| Bundle.entry[19].resource[0].hasMember[14].reference[0] | Observation/org52-cefotaxime |
| Bundle.entry[19].resource[0].hasMember[15].reference[0] | Observation/org52-ceftazidime |
| Bundle.entry[19].resource[0].hasMember[16].reference[0] | Observation/org52-meropenem |
| Bundle.entry[20].fullUrl[0] | https://acme.org/Observation/org52-ampicilin |
| Bundle.entry[20].resource[0].id[0] | org52-ampicilin |
| Bundle.entry[20].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[20].resource[0].text[0].status[0] | empty |
| Bundle.entry[20].resource[0].text[0].div[0] | empty |
| Bundle.entry[20].resource[0].status[0] | final |
| Bundle.entry[20].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[20].resource[0].code[0].coding[0].code[0] | 29-9 |
| Bundle.entry[20].resource[0].code[0].coding[0].display[0] | Ampicillin [Susceptibility] by Disk diffusion (KB) |
| Bundle.entry[20].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[20].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[20].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[20].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[20].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[20].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[20].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[21].fullUrl[0] | https://acme.org/Observation/org52-trimethoprim-sulfamethoxazole |
| Bundle.entry[21].resource[0].id[0] | org52-trimethoprim-sulfamethoxazole |
| Bundle.entry[21].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[21].resource[0].text[0].status[0] | empty |
| Bundle.entry[21].resource[0].text[0].div[0] | empty |
| Bundle.entry[21].resource[0].status[0] | final |
| Bundle.entry[21].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[21].resource[0].code[0].coding[0].code[0] | 516-5 |
| Bundle.entry[21].resource[0].code[0].coding[0].display[0] | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[21].resource[0].code[0].text[0] | Trimethoprim+Sulfamethoxazole |
| Bundle.entry[21].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[21].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[21].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[21].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[21].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[21].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[21].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[22].fullUrl[0] | https://acme.org/Observation/org52-nitrofurantoin |
| Bundle.entry[22].resource[0].id[0] | org52-nitrofurantoin |
| Bundle.entry[22].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[22].resource[0].text[0].status[0] | empty |
| Bundle.entry[22].resource[0].text[0].div[0] | empty |
| Bundle.entry[22].resource[0].status[0] | final |
| Bundle.entry[22].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[22].resource[0].code[0].coding[0].code[0] | 363-2 |
| Bundle.entry[22].resource[0].code[0].coding[0].display[0] | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[22].resource[0].code[0].text[0] | Nitrofurantoin |
| Bundle.entry[22].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[22].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[22].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[22].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[22].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[22].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[22].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[23].fullUrl[0] | https://acme.org/Observation/org52-cefuroxime |
| Bundle.entry[23].resource[0].id[0] | org52-cefuroxime |
| Bundle.entry[23].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[23].resource[0].text[0].status[0] | empty |
| Bundle.entry[23].resource[0].text[0].div[0] | empty |
| Bundle.entry[23].resource[0].status[0] | final |
| Bundle.entry[23].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[23].resource[0].code[0].coding[0].code[0] | 51774-8 |
| Bundle.entry[23].resource[0].code[0].coding[0].display[0] | Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[23].resource[0].code[0].text[0] | Cefuroxime |
| Bundle.entry[23].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[23].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[23].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[23].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[23].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[23].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[23].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[24].fullUrl[0] | https://acme.org/Observation/org52-gentamicin |
| Bundle.entry[24].resource[0].id[0] | org52-gentamicin |
| Bundle.entry[24].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[24].resource[0].text[0].status[0] | empty |
| Bundle.entry[24].resource[0].text[0].div[0] | empty |
| Bundle.entry[24].resource[0].status[0] | final |
| Bundle.entry[24].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[24].resource[0].code[0].coding[0].code[0] | 267-5 |
| Bundle.entry[24].resource[0].code[0].coding[0].display[0] | Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[24].resource[0].code[0].text[0] | Gentamicin |
| Bundle.entry[24].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[24].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[24].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[24].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[24].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[24].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[24].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[25].fullUrl[0] | https://acme.org/Observation/org52-colistin |
| Bundle.entry[25].resource[0].id[0] | org52-colistin |
| Bundle.entry[25].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[25].resource[0].text[0].status[0] | empty |
| Bundle.entry[25].resource[0].text[0].div[0] | empty |
| Bundle.entry[25].resource[0].status[0] | final |
| Bundle.entry[25].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[25].resource[0].code[0].coding[0].code[0] | 205-5 |
| Bundle.entry[25].resource[0].code[0].coding[0].display[0] | Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[25].resource[0].code[0].text[0] | Colistin |
| Bundle.entry[25].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[25].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[25].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[25].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[25].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[25].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[25].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[26].fullUrl[0] | https://acme.org/Observation/org52-temocillin |
| Bundle.entry[26].resource[0].id[0] | org52-temocillin |
| Bundle.entry[26].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[26].resource[0].text[0].status[0] | empty |
| Bundle.entry[26].resource[0].text[0].div[0] | empty |
| Bundle.entry[26].resource[0].status[0] | final |
| Bundle.entry[26].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[26].resource[0].code[0].coding[0].code[0] | 492-9 |
| Bundle.entry[26].resource[0].code[0].coding[0].display[0] | Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[26].resource[0].code[0].text[0] | Temocillin |
| Bundle.entry[26].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[26].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[26].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[26].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[26].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[26].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[26].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[27].fullUrl[0] | https://acme.org/Observation/org52-fosfomycin |
| Bundle.entry[27].resource[0].id[0] | org52-fosfomycin |
| Bundle.entry[27].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[27].resource[0].text[0].status[0] | empty |
| Bundle.entry[27].resource[0].text[0].div[0] | empty |
| Bundle.entry[27].resource[0].status[0] | final |
| Bundle.entry[27].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[27].resource[0].code[0].coding[0].code[0] | 25653-7 |
| Bundle.entry[27].resource[0].code[0].coding[0].display[0] | Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[27].resource[0].code[0].text[0] | Fosfomycin |
| Bundle.entry[27].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[27].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[27].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[27].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[27].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[27].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[27].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[28].fullUrl[0] | https://acme.org/Observation/org52-levofloxacin |
| Bundle.entry[28].resource[0].id[0] | org52-levofloxacin |
| Bundle.entry[28].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[28].resource[0].text[0].status[0] | empty |
| Bundle.entry[28].resource[0].text[0].div[0] | empty |
| Bundle.entry[28].resource[0].status[0] | final |
| Bundle.entry[28].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[28].resource[0].code[0].coding[0].code[0] | 20396-8 |
| Bundle.entry[28].resource[0].code[0].coding[0].display[0] | levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[28].resource[0].code[0].text[0] | Levofloxacin |
| Bundle.entry[28].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[28].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[28].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[28].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[28].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[28].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[28].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[29].fullUrl[0] | https://acme.org/Observation/org52-ofloxacin |
| Bundle.entry[29].resource[0].id[0] | org52-ofloxacin |
| Bundle.entry[29].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[29].resource[0].text[0].status[0] | empty |
| Bundle.entry[29].resource[0].text[0].div[0] | empty |
| Bundle.entry[29].resource[0].status[0] | final |
| Bundle.entry[29].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[29].resource[0].code[0].coding[0].code[0] | 375-6 |
| Bundle.entry[29].resource[0].code[0].coding[0].display[0] | Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[29].resource[0].code[0].text[0] | Ofloxacin |
| Bundle.entry[29].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[29].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[29].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[29].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[29].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[29].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[29].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[30].fullUrl[0] | https://acme.org/Observation/org52-amoxicillin-clavulanate |
| Bundle.entry[30].resource[0].id[0] | org52-amoxicillin-clavulanate |
| Bundle.entry[30].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[30].resource[0].text[0].status[0] | empty |
| Bundle.entry[30].resource[0].text[0].div[0] | empty |
| Bundle.entry[30].resource[0].status[0] | final |
| Bundle.entry[30].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[30].resource[0].code[0].coding[0].code[0] | 20-8 |
| Bundle.entry[30].resource[0].code[0].coding[0].display[0] | Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[30].resource[0].code[0].text[0] | Amoxicillin+Clavulanate |
| Bundle.entry[30].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[30].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[30].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[30].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[30].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[30].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[30].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[31].fullUrl[0] | https://acme.org/Observation/org52-amikacin |
| Bundle.entry[31].resource[0].id[0] | org52-amikacin |
| Bundle.entry[31].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[31].resource[0].text[0].status[0] | empty |
| Bundle.entry[31].resource[0].text[0].div[0] | empty |
| Bundle.entry[31].resource[0].status[0] | final |
| Bundle.entry[31].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[31].resource[0].code[0].coding[0].code[0] | 12-5 |
| Bundle.entry[31].resource[0].code[0].coding[0].display[0] | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[31].resource[0].code[0].text[0] | Amikacin |
| Bundle.entry[31].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[31].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[31].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[31].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[31].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[31].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[31].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[32].fullUrl[0] | https://acme.org/Observation/org52-piperacillin-tazobactam |
| Bundle.entry[32].resource[0].id[0] | org52-piperacillin-tazobactam |
| Bundle.entry[32].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[32].resource[0].text[0].status[0] | empty |
| Bundle.entry[32].resource[0].text[0].div[0] | empty |
| Bundle.entry[32].resource[0].status[0] | final |
| Bundle.entry[32].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[32].resource[0].code[0].coding[0].code[0] | 412-7 |
| Bundle.entry[32].resource[0].code[0].coding[0].display[0] | Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[32].resource[0].code[0].text[0] | Piperacillin+Tazobactam |
| Bundle.entry[32].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[32].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[32].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[32].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[32].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[32].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[32].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[33].fullUrl[0] | https://acme.org/Observation/org52-ceftriaxone |
| Bundle.entry[33].resource[0].id[0] | org52-ceftriaxone |
| Bundle.entry[33].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[33].resource[0].text[0].status[0] | empty |
| Bundle.entry[33].resource[0].text[0].div[0] | empty |
| Bundle.entry[33].resource[0].status[0] | final |
| Bundle.entry[33].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[33].resource[0].code[0].coding[0].code[0] | 141-2 |
| Bundle.entry[33].resource[0].code[0].coding[0].display[0] | cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[33].resource[0].code[0].text[0] | Ceftriaxone |
| Bundle.entry[33].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[33].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[33].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[33].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[33].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[33].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[33].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[34].fullUrl[0] | https://acme.org/Observation/org52-cefotaxime |
| Bundle.entry[34].resource[0].id[0] | org52-cefotaxime |
| Bundle.entry[34].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[34].resource[0].text[0].status[0] | empty |
| Bundle.entry[34].resource[0].text[0].div[0] | empty |
| Bundle.entry[34].resource[0].status[0] | final |
| Bundle.entry[34].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[34].resource[0].code[0].coding[0].code[0] | 108-1 |
| Bundle.entry[34].resource[0].code[0].coding[0].display[0] | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[34].resource[0].code[0].text[0] | Cefotaxime |
| Bundle.entry[34].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[34].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[34].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[34].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[34].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[34].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[34].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[35].fullUrl[0] | https://acme.org/Observation/org52-ceftazidime |
| Bundle.entry[35].resource[0].id[0] | org52-ceftazidime |
| Bundle.entry[35].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[35].resource[0].text[0].status[0] | empty |
| Bundle.entry[35].resource[0].text[0].div[0] | empty |
| Bundle.entry[35].resource[0].status[0] | final |
| Bundle.entry[35].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[35].resource[0].code[0].coding[0].code[0] | 133-9 |
| Bundle.entry[35].resource[0].code[0].coding[0].display[0] | cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[35].resource[0].code[0].text[0] | Ceftazidime |
| Bundle.entry[35].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[35].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[35].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[35].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[35].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[35].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[35].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[36].fullUrl[0] | https://acme.org/Observation/org52-meropenem |
| Bundle.entry[36].resource[0].id[0] | org52-meropenem |
| Bundle.entry[36].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[36].resource[0].text[0].status[0] | empty |
| Bundle.entry[36].resource[0].text[0].div[0] | empty |
| Bundle.entry[36].resource[0].status[0] | final |
| Bundle.entry[36].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[36].resource[0].code[0].coding[0].code[0] | 6652-2 |
| Bundle.entry[36].resource[0].code[0].coding[0].display[0] | Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Bundle.entry[36].resource[0].code[0].text[0] | Meropenem |
| Bundle.entry[36].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[36].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[36].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[36].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[36].resource[0].interpretation[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation |
| Bundle.entry[36].resource[0].interpretation[0].coding[0].code[0] | S |
| Bundle.entry[36].resource[0].interpretation[0].coding[0].display[0] | Susceptible |
| Bundle.entry[37].fullUrl[0] | https://acme.org/Observation/dr50-mrsa |
| Bundle.entry[37].resource[0].id[0] | dr50-mrsa |
| Bundle.entry[37].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[37].resource[0].text[0].status[0] | empty |
| Bundle.entry[37].resource[0].text[0].div[0] | empty |
| Bundle.entry[37].resource[0].status[0] | final |
| Bundle.entry[37].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[37].resource[0].code[0].coding[0].code[0] | 35492-8 |
| Bundle.entry[37].resource[0].code[0].coding[0].display[0] | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Specimen by NAA with probe detection |
| Bundle.entry[37].resource[0].code[0].text[0] | MRSA |
| Bundle.entry[37].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[37].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[37].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[37].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[37].resource[0].valueString[0] | negative |
| Bundle.entry[38].fullUrl[0] | https://acme.org/Observation/dr50-mrgn |
| Bundle.entry[38].resource[0].id[0] | dr50-mrgn |
| Bundle.entry[38].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult |
| Bundle.entry[38].resource[0].text[0].status[0] | empty |
| Bundle.entry[38].resource[0].text[0].div[0] | empty |
| Bundle.entry[38].resource[0].status[0] | final |
| Bundle.entry[38].resource[0].code[0].coding[0].system[0] | http://loinc.org |
| Bundle.entry[38].resource[0].code[0].coding[0].code[0] | 78702-8 |
| Bundle.entry[38].resource[0].code[0].coding[0].display[0] | Multiple drug resistant gram negative organism [Identifier] in Specimen by Culture |
| Bundle.entry[38].resource[0].code[0].text[0] | MRGN |
| Bundle.entry[38].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[38].resource[0].effectiveDateTime[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[38].resource[0].issued[0] | 2015-11-04T09:16:00-05:00 |
| Bundle.entry[38].resource[0].performer[0].reference[0] | Organization/organization10 |
| Bundle.entry[38].resource[0].valueString[0] | negative |
| Bundle.entry[39].fullUrl[0] | https://acme.org/Organization/organization10 |
| Bundle.entry[39].resource[0].id[0] | organization10 |
| Bundle.entry[39].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-HealthcareOrganization-Organization |
| Bundle.entry[39].resource[0].text[0].status[0] | empty |
| Bundle.entry[39].resource[0].text[0].div[0] | empty |
| Bundle.entry[39].resource[0].identifier[0].use[0] | official |
| Bundle.entry[39].resource[0].identifier[0].type[0].coding[0].system[0] | http://terminology.hl7.org/CodeSystem/v2-0203 |
| Bundle.entry[39].resource[0].identifier[0].type[0].coding[0].code[0] | MD |
| Bundle.entry[39].resource[0].identifier[0].type[0].coding[0].display[0] | Medical License number |
| Bundle.entry[39].resource[0].identifier[0].system[0] | https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi |
| Bundle.entry[39].resource[0].identifier[0].value[0] | 81165343998 |
| Bundle.entry[39].resource[0].active[0] | True |
| Bundle.entry[39].resource[0].type[0].coding[0].system[0] | https://www.ehealth.fgov.be/standards/fhir/core/CodeSystem/cd-hcparty |
| Bundle.entry[39].resource[0].type[0].coding[0].code[0] | orglaboratory |
| Bundle.entry[39].resource[0].name[0] | GTL - General Testing Laboratory |
| Bundle.entry[39].resource[0].telecom[0].system[0] | phone |
| Bundle.entry[39].resource[0].telecom[0].value[0] | 322675199 |
| Bundle.entry[39].resource[0].telecom[0].use[0] | work |
| Bundle.entry[39].resource[0].address[0].extension[0].url[0] | http://hl7.org/fhir/StructureDefinition/language |
| Bundle.entry[39].resource[0].address[0].extension[0].valueCode[0] | nl |
| Bundle.entry[39].resource[0].address[0].use[0] | work |
| Bundle.entry[39].resource[0].address[0].type[0] | both |
| Bundle.entry[39].resource[0].address[0].text[0] | Vulcansstraat 120, 1000 Brussel |
| Bundle.entry[39].resource[0].address[0].line[0] | Vulcansstraat 120 |
| Bundle.entry[39].resource[0].address[0].line[0].extension[0].url[0] | http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName |
| Bundle.entry[39].resource[0].address[0].line[0].extension[0].valueString[0] | Vulcansstraat |
| Bundle.entry[39].resource[0].address[0].line[0].extension[1].url[0] | http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber |
| Bundle.entry[39].resource[0].address[0].line[0].extension[1].valueString[0] | 120 |
| Bundle.entry[39].resource[0].address[0].city[0] | Brussel |
| Bundle.entry[39].resource[0].address[0].postalCode[0] | 1000 |
| Bundle.entry[39].resource[0].address[0].country[0] | BE |
| Bundle.entry[40].fullUrl[0] | https://acme.org/Patient/patient1 |
| Bundle.entry[40].resource[0].id[0] | patient1 |
| Bundle.entry[40].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-Patient |
| Bundle.entry[40].resource[0].text[0].status[0] | empty |
| Bundle.entry[40].resource[0].text[0].div[0] | empty |
| Bundle.entry[40].resource[0].identifier[0].use[0] | official |
| Bundle.entry[40].resource[0].identifier[0].system[0] | https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/ssin |
| Bundle.entry[40].resource[0].identifier[0].value[0] | 79121137740 |
| Bundle.entry[40].resource[0].active[0] | True |
| Bundle.entry[40].resource[0].name[0].family[0] | La Paradisio |
| Bundle.entry[40].resource[0].name[0].given[0] | Josephine |
| Bundle.entry[40].resource[0].name[0].given[1] | Nessa |
| Bundle.entry[40].resource[0].telecom[0].system[0] | |
| Bundle.entry[40].resource[0].telecom[0].value[0] | nessa.laparadisio@belgium.be |
| Bundle.entry[40].resource[0].telecom[1].system[0] | phone |
| Bundle.entry[40].resource[0].telecom[1].value[0] | +322476792979 |
| Bundle.entry[40].resource[0].telecom[1].use[0] | mobile |
| Bundle.entry[40].resource[0].telecom[2].system[0] | phone |
| Bundle.entry[40].resource[0].telecom[2].value[0] | +3226718655 |
| Bundle.entry[40].resource[0].telecom[2].use[0] | home |
| Bundle.entry[40].resource[0].telecom[3].system[0] | phone |
| Bundle.entry[40].resource[0].telecom[3].value[0] | +322476799 |
| Bundle.entry[40].resource[0].telecom[3].use[0] | work |
| Bundle.entry[40].resource[0].gender[0] | female |
| Bundle.entry[40].resource[0].birthDate[0] | 1979-12-11 |
| Bundle.entry[40].resource[0].birthDate[0].extension[0].url[0] | http://hl7.org/fhir/StructureDefinition/patient-birthTime |
| Bundle.entry[40].resource[0].birthDate[0].extension[0].valueDateTime[0] | 1979-12-11T13:28:17-05:00 |
| Bundle.entry[40].resource[0].address[0].extension[0].url[0] | http://hl7.org/fhir/StructureDefinition/language |
| Bundle.entry[40].resource[0].address[0].extension[0].valueCode[0] | nl |
| Bundle.entry[40].resource[0].address[0].use[0] | home |
| Bundle.entry[40].resource[0].address[0].type[0] | both |
| Bundle.entry[40].resource[0].address[0].text[0] | Sloordelle 42, 1160 Oudergem |
| Bundle.entry[40].resource[0].address[0].line[0] | Sloordelle 42 |
| Bundle.entry[40].resource[0].address[0].city[0] | Oudergem |
| Bundle.entry[40].resource[0].address[0].postalCode[0] | 1160 |
| Bundle.entry[40].resource[0].address[0].country[0] | BE |
| Bundle.entry[41].fullUrl[0] | https://acme.org/ServiceRequest/servicerequest50 |
| Bundle.entry[41].resource[0].id[0] | servicerequest50 |
| Bundle.entry[41].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-LaboratoryTestResult.Requester |
| Bundle.entry[41].resource[0].text[0].status[0] | empty |
| Bundle.entry[41].resource[0].text[0].div[0] | empty |
| Bundle.entry[41].resource[0].identifier[0].system[0] | https://www.GTL-LABO.be/orderingsystem |
| Bundle.entry[41].resource[0].identifier[0].value[0] | 12334546 |
| Bundle.entry[41].resource[0].status[0] | active |
| Bundle.entry[41].resource[0].intent[0] | order |
| Bundle.entry[41].resource[0].category[0].coding[0].system[0] | http://snomed.info/sct |
| Bundle.entry[41].resource[0].category[0].coding[0].code[0] | 108252007 |
| Bundle.entry[41].resource[0].category[0].coding[0].display[0] | Laboratory procedure |
| Bundle.entry[41].resource[0].subject[0].reference[0] | Patient/patient1 |
| Bundle.entry[41].resource[0].authoredOn[0] | 2015-11-01T14:41:00+01:00 |
| Bundle.entry[41].resource[0].requester[0].reference[0] | Practitioner/practitioner1 |
| Bundle.entry[41].resource[0].specimen[0].reference[0] | Specimen/specimen50 |
| Bundle.entry[42].fullUrl[0] | https://acme.org/Practitioner/practitioner1 |
| Bundle.entry[42].resource[0].id[0] | practitioner1 |
| Bundle.entry[42].resource[0].meta[0].profile[0] | https://fhir.healthdata.be/StructureDefinition/HdBe-HealthProfessional-Practitioner |
| Bundle.entry[42].resource[0].text[0].status[0] | empty |
| Bundle.entry[42].resource[0].text[0].div[0] | empty |
| Bundle.entry[42].resource[0].identifier[0].use[0] | official |
| Bundle.entry[42].resource[0].identifier[0].system[0] | https://www.ehealth.fgov.be/standards/fhir/core/NamingSystem/nihdi |
| Bundle.entry[42].resource[0].identifier[0].value[0] | 18749704477 |
| Bundle.entry[42].resource[0].name[0].use[0] | official |
| Bundle.entry[42].resource[0].name[0].family[0] | Pulaski |
| Bundle.entry[42].resource[0].name[0].given[0] | Katherine |
| Bundle.entry[42].resource[0].name[0].given[0].extension[0].url[0] | http://hl7.org/fhir/StructureDefinition/iso21090-EN-qualifier |
| Bundle.entry[42].resource[0].name[0].given[0].extension[0].valueCode[0] | BR |
| Bundle.entry[42].resource[0].name[0].suffix[0] | MD |
| Bundle.entry[42].resource[0].telecom[0].system[0] | |
| Bundle.entry[42].resource[0].telecom[0].value[0] | katherine.pulaski@enterprisehospital.be |
| Bundle.entry[42].resource[0].telecom[0].use[0] | work |
| Bundle.entry[42].resource[0].telecom[1].system[0] | phone |
| Bundle.entry[42].resource[0].telecom[1].value[0] | 022675198 |
| Bundle.entry[42].resource[0].telecom[1].use[0] | work |
| Bundle.entry[42].resource[0].telecom[2].system[0] | fax |
| Bundle.entry[42].resource[0].telecom[2].value[0] | 022675209 |
| Bundle.entry[42].resource[0].telecom[2].use[0] | work |
| Bundle.entry[42].resource[0].address[0].extension[0].url[0] | http://hl7.org/fhir/StructureDefinition/language |
| Bundle.entry[42].resource[0].address[0].extension[0].valueCode[0] | nl |
| Bundle.entry[42].resource[0].address[0].use[0] | home |
| Bundle.entry[42].resource[0].address[0].text[0] | Jupiterlaan 5, 1853 Grimbergen |
| Bundle.entry[42].resource[0].address[0].line[0] | Jupiterlaan 5 |
| Bundle.entry[42].resource[0].address[0].city[0] | Grimbergen |
| Bundle.entry[42].resource[0].address[0].postalCode[0] | 1853 |
| Bundle.entry[42].resource[0].address[0].country[0] | BE |